Many providers are increasingly prescribing them for patients with overlapping conditions such as obesity, cardiovascular risk, kidney disease, and more
Key Takeaway Sulphur burps on GLP-1 injections are common but usually short-lived
Phase 2 clinical trials involved 338 adults with obesity (BMI 30 or more) and overweight (BMI of 2729.99) with one or more weight-related conditions such as high blood pressure, high cholesterol levels, heart disease, and type 2 diabetes
Individuals with obesity often exhibit impaired GLP-1 signaling, which contributes to persistent hunger, reduced satiety, and unstable blood sugar patterns that encourage overeating
Thyroid panel (TSH, Free T4, Free T3) thyroid dysfunction is a major cause of hair loss and should always be ruled out
Available in most states* Introduction to GLP-1s for weight loss What GLP-1 medications are available through Walgreens Weight Management